Patrick Labonté

1.0k total citations
35 papers, 839 citations indexed

About

Patrick Labonté is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Patrick Labonté has authored 35 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 16 papers in Epidemiology and 8 papers in Infectious Diseases. Recurrent topics in Patrick Labonté's work include Hepatitis C virus research (16 papers), Hepatitis B Virus Studies (11 papers) and Autophagy in Disease and Therapy (5 papers). Patrick Labonté is often cited by papers focused on Hepatitis C virus research (16 papers), Hepatitis B Virus Studies (11 papers) and Autophagy in Disease and Therapy (5 papers). Patrick Labonté collaborates with scholars based in Canada, France and United States. Patrick Labonté's co-authors include Matthieu Blanchet, Carl Guévin, Nabil G. Seidah, Paul Mak, Ahmed M. Fahmy, Camille Sureau, Andrew Vaillant, Kouacou V. Konan, Gaétan Mayer and Nasha Nassoury and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.

In The Last Decade

Patrick Labonté

35 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Labonté Canada 14 446 303 213 140 124 35 839
Olivier Diaz France 18 596 1.3× 405 1.3× 335 1.6× 104 0.7× 118 1.0× 30 1.2k
Yutaka Amako United States 11 338 0.8× 384 1.3× 251 1.2× 47 0.3× 75 0.6× 13 781
Janisha Patel United Kingdom 13 440 1.0× 154 0.5× 228 1.1× 80 0.6× 249 2.0× 19 837
Serban Morosan France 12 230 0.5× 404 1.3× 263 1.2× 228 1.6× 47 0.4× 19 858
Penelope Mavromara Greece 23 613 1.4× 760 2.5× 425 2.0× 45 0.3× 125 1.0× 68 1.4k
William R. Addison Canada 14 626 1.4× 646 2.1× 379 1.8× 108 0.8× 142 1.1× 24 1.3k
Maud Michelet France 15 533 1.2× 407 1.3× 267 1.3× 35 0.3× 111 0.9× 30 866
Rongjuan Pei China 20 464 1.0× 403 1.3× 312 1.5× 28 0.2× 158 1.3× 36 866
Gabrielle Vièyres Germany 20 663 1.5× 883 2.9× 296 1.4× 53 0.4× 182 1.5× 31 1.4k
Marie-Anne Petit France 18 612 1.4× 589 1.9× 198 0.9× 57 0.4× 102 0.8× 35 968

Countries citing papers authored by Patrick Labonté

Since Specialization
Citations

This map shows the geographic impact of Patrick Labonté's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Labonté with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Labonté more than expected).

Fields of papers citing papers by Patrick Labonté

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Labonté. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Labonté. The network helps show where Patrick Labonté may publish in the future.

Co-authorship network of co-authors of Patrick Labonté

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Labonté. A scholar is included among the top collaborators of Patrick Labonté based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Labonté. Patrick Labonté is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blanchet, Matthieu, et al.. (2024). HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression. Viruses. 16(4). 532–532. 1 indexed citations
2.
Blanchet, Matthieu, et al.. (2024). Exosomes as Conduits: Facilitating Hepatitis B Virus-Independent Hepatitis D Virus Transmission and Propagation in Hepatocytes. Viruses. 16(6). 825–825. 3 indexed citations
3.
Vaillant, Andrew, et al.. (2023). Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen. PLoS ONE. 18(11). e0293167–e0293167. 1 indexed citations
4.
Adejumo, Adeyinka, Patrick Labonté, & Terence N. Bukong. (2021). Relationship Between Recreational Cannabis Use and Helicobacter pylori Infection. Cannabis and Cannabinoid Research. 8(3). 537–546. 4 indexed citations
5.
Li, Jingjing, et al.. (2020). Reticulon-3 modulates the incorporation of replication competent hepatitis C virus molecules for release inside infectious exosomes. PLoS ONE. 15(9). e0239153–e0239153. 8 indexed citations
6.
Blanchet, Matthieu, et al.. (2020). Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro. Antiviral Research. 183. 104853–104853. 46 indexed citations
7.
Blanchet, Matthieu, et al.. (2019). Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells. Antiviral Research. 164. 97–105. 49 indexed citations
8.
9.
Fahmy, Ahmed M., Myriam Létourneau, David Chatenet, et al.. (2016). Effect of the pituitary adenylate cyclase-activating polypeptide on the autophagic activation observed in in vitro and in vivo models of Parkinson's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(4). 688–695. 25 indexed citations
10.
Blanchet, Matthieu, et al.. (2016). Statins can exert dual, concentration dependent effects on HCV entry in vitro. Antiviral Research. 128. 43–48. 10 indexed citations
11.
Blanchet, Matthieu, Camille Sureau, Carl Guévin, Nabil G. Seidah, & Patrick Labonté. (2015). SKI-1/S1P inhibitor PF-429242 impairs the onset of HCV infection. Antiviral Research. 115. 94–104. 32 indexed citations
12.
13.
Blanchet, Matthieu, Nabil G. Seidah, & Patrick Labonté. (2012). SKI-1/S1P inhibition: A promising surrogate to statins to block Hepatitis C virus replication. Antiviral Research. 95(2). 159–166. 25 indexed citations
14.
Guévin, Carl, Alain Lamarre, & Patrick Labonté. (2009). Novel HCV replication mouse model using human hepatocellular carcinoma xenografts. Antiviral Research. 84(1). 14–22. 12 indexed citations
15.
Labonté, Patrick, Carl Guévin, Marie‐Claude Asselin, et al.. (2009). PCSK9 impedes hepatitis C virus infection in vitro and modulates liver CD81 expression #. Hepatology. 50(1). 17–24. 124 indexed citations
16.
Ekaza, Euloge, et al.. (2008). Hepatitis C virus infection in Abidjan Cote d Ivoire: heterogeneity of genotypes. EspaceINRS (National Institute for Scientific Research (Canada)). 2 indexed citations
17.
Labonté, Patrick & Nabil G. Seidah. (2008). Emerging viruses: risk of pandemic. Expert Review of Anti-infective Therapy. 6(5). 581–583. 2 indexed citations
18.
Amin, Anthony A., Stéphane Olland, Mark Orlowski, et al.. (2003). Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase. Virology. 313(1). 158–169. 9 indexed citations
19.
Labonté, Patrick, et al.. (2002). Basal replication of hepatitis C virus in nude mice harboring human tumor. Journal of Medical Virology. 66(3). 312–319. 4 indexed citations
20.
Labonté, Patrick, et al.. (2002). Modulation of Hepatitis C Virus RNA-dependent RNA Polymerase Activity by Structure-based Site-directed Mutagenesis. Journal of Biological Chemistry. 277(41). 38838–38846. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivier Diaz Breakdown of academic impact, for papers by Yutaka Amako Breakdown of academic impact, for papers by Janisha Patel Breakdown of academic impact, for papers by Serban Morosan Breakdown of academic impact, for papers by Penelope Mavromara Breakdown of academic impact, for papers by William R. Addison Breakdown of academic impact, for papers by Maud Michelet Breakdown of academic impact, for papers by Rongjuan Pei Breakdown of academic impact, for papers by Gabrielle Vièyres Breakdown of academic impact, for papers by Marie-Anne Petit
Rankless by CCL
2026